Aperture Therapeutics

📍 San Carlos, United States🗓 Founded 2022👥 5 employees💰 Last funded Feb 2025
Biotechnology Research🌐 aperturetx.com
Website LinkedIn
Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodegeneration. The companys innovative platform leverages insight into disease resilience from large genomic and clinical data with streamlined drug discovery platform that generates drugs mimicking the effects of protective human gene variants.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Aperture Therapeutics?
Aperture Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Aperture Therapeutics last raise funding?
The most recent investment in Aperture Therapeutics recorded on gritt.io was in February 2025.
When was Aperture Therapeutics founded?
Aperture Therapeutics was founded in 2022.
What industry is Aperture Therapeutics in?
Aperture Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aperture Therapeutics based?
Aperture Therapeutics is headquartered in San Carlos, United States.